NIH awards grant to CerSci Therapeutics for a preclinical trial to explore the development of a potentially new Migraine treatment blocking the free radical, peroxynitrite. This is just the first of many new studies we can expect as researchers work to develop better, safer treatments for Migraine.
Everyone feels anxious on occasion. It's a normal, healthy emotion that alerts us to possible threats. It's only problematic when our natural alarm sounds during otherwise safe situations. Anxiety is one of several associated symptoms of a Migraine attack. After all, the pain and emotion pathways in the brain are closely linked.
This is a transcript of an interview with Dr. Peter Goadsby. I had the privilege of meeting with him in San Francisco at the June 2018 AHS Scientific Meeting. In the interview, we discussed the recent results of the Autonomic Technologies CH-2 clinical trial of their sphenopalatine ganglion microstimulator system.
When we make a special effort to come together, we are more powerful. Efforts that, in some way, reflect each other get more attention from the general public and are generally more effective. Sometimes we can best further the cause of Migraine advocacy by joining in on someone else's great idea. When we are unified, the message is magnified.